Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies. | J Pathol Transl Med | 2022 | 35843627 | PubTator, text mining | PubMed |
| Organ-specific host differential gene expression analysis in systemic candidiasis: A systems biology approach. | Microb Pathog | 2022 | 35839997 | PubTator, text mining | PubMed |
| Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. | Blood | 2022 | 35839448 | PubTator, text mining | PubMed |
| The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics. | Leuk Res Rep | 2022 | 35832747 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma. | Front Oncol | 2022 | 35832546 | PubTator, text mining | PubMed |
| Your height affects your health: genetic determinants and health-related outcomes in Taiwan. | BMC Med | 2022 | 35831902 | PubTator, text mining | PubMed |
| Detection of cell markers from single cell RNA-seq with sc2marker. | BMC Bioinformatics | 2022 | 35831796 | PubTator, text mining | PubMed |
| Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. | J Exp Med | 2022 | 35819358 | PubTator, text mining | PubMed |
| Neonatal congenital leukemia caused by several missense mutations and AFF1-KMT2A fusion: A case report. | Oncol Lett | 2022 | 35814831 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. | J Clin Med | 2022 | 35807041 | PubTator, text mining | PubMed |
| Prospective Proteomic Study Identifies Potential Circulating Protein Biomarkers for Colorectal Cancer Risk. | Cancers (Basel) | 2022 | 35805033 | PubTator, text mining | PubMed |
| Detecting lineage-defining mutations in SARS-CoV-2 using colorimetric RT-LAMP without probes or additional primers. | Sci Rep | 2022 | 35798777 | PubTator, text mining | PubMed |
| Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis. | Front Oncol | 2022 | 35795062 | PubTator, text mining | PubMed |
| Effects on physiologic measures of appetite from intragastric balloon and endoscopic sleeve gastroplasty: results of a prospective study. | Chin Med J (Engl) | 2022 | 35788090 | PubTator, text mining | PubMed |
| SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma. | Clin Lymphoma Myeloma Leuk | 2022 | 35787364 | PubTator, text mining | PubMed |
| Integrated Analysis of Immune-Related circRNA-miRNA-mRNA Regulatory Network in Ischemic Stroke. | Front Neurol | 2022 | 35785353 | PubTator, text mining | PubMed |
| Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma. | Ther Adv Hematol | 2022 | 35785244 | PubTator, text mining | PubMed |
| Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series. | Front Oncol | 2022 | 35785180 | PubTator, text mining | PubMed |
| Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction. | Front Cardiovasc Med | 2022 | 35783838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=61